COMMUNIQUÉS West-GlobeNewswire

Maverick Technology Solutions Receives Approval for Name Change and Symbol Change
20/09/2018
Concludes Final Step of Its Merger RENO, Nev., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions, developer and manufacturer of the ROSINBOMB brand of industry leading consumer and commercial rosin [...]
Cocrystal Pharma Completes Patient Enrollment in Phase 2a Study Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C
20/09/2018
ATLANTA, GA and BOTHELL, WA, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]
Tabula Rasa HealthCare Brings Together PACE Medical Directors at 2018 Clinical Advisory Panel Meeting
20/09/2018
TRHC Clinical Pharmacists and PACE Medical Directors Gather to Learn MOORESTOWN, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- CareKinesis, a subsidiary of Tabula Rasa HealthCare (NASDAQ:TRHC), is hosting its 12 th Clinical [...]
Avalon GloboCare Commences Operation of its Core GMP Platform, Epicon Biotech, to Facilitate Clinical Development of Cellular Therapies
20/09/2018
FREEHOLD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company has officially commenced operation of [...]
Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering
20/09/2018
New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. ( NASDAQ: PRPO ), announced today the launch of a [...]
Integrated Cannabis Company, Inc. Signs Distribution Agreement with Empower Clinics, Inc.
20/09/2018
VANCOUVER, British Columbia, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ”), is pleased to announce the completion of a Letter of Intent (LOI) to [...]
Conatus Pharmaceuticals to Host Analyst and Investor Symposium on Portal Hypertension
20/09/2018
SAN DIEGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development of novel medicines to treat liver disease, will host an invitation-only [...]
FDA Accepts Asterias Biotherapeutics’ Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Clinical Program
20/09/2018
FREMONT, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions [...]
Axovant to Present at Two Upcoming Investor Conferences
20/09/2018
BASEL, Switzerland, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON) today announced that Pavan Cheruvu, M.D., chief executive officer, will present a corporate overview at the Jefferies Gene Therapy [...]
Aleafia Partners With Cronos Group on Medical Cannabis Sleep Study
20/09/2018
TORONTO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) and Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”) are pleased to announce the [...]
Summit Reports Financial Results for the Second Quarter Ended 31 July 2018 and Operational Progress
20/09/2018
Summit Therapeutics plc (‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results for the Second Quarter and Half Year Ended 31 July 2018 and Operational Progress Oxford, UK, and Cambridge, [...]
Health Canada has authorized TAKHZYRO(TM) (lanadelumab injection), a first-of-its-kind monoclonal antibody treatment for the prevention of hereditary angioedema (HAE) attacks
20/09/2018
Health Canada has authorized TAKHZYRO TM (lanadelumab injection), a first-of-its-kind monoclonal antibody treatment for the prevention of hereditary angioedema (HAE) attacks New treatment option for HAE receives first [...]
Santé Canada autorise TAKHZYRO(MC) (lanadelumab en injection), le premier traitement à anticorps monoclonal en son genre destiné à la prévention de crises d’angioœdème héréditaire (AOH)
20/09/2018
Santé Canada autorise TAKHZYRO MC (lanadelumab en injection), le premier traitement à anticorps monoclonal en son genre destiné à la prévention de crises d’angioœdème héréditaire (AOH) Une nouvelle option de traitement [...]
Tonix Pharmaceuticals to Present at Sidoti & Company Fall 2018 Investor Conference
20/09/2018
NEW YORK, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present and host [...]
RedHill Biopharma to Present at Ladenburg Thalmann 2018 Healthcare Conference
20/09/2018
TEL-AVIV, Israel and RALEIGH, N.C., Sept. 20, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Canada House Wellness Group Announces $25,000,000 Financing and Issuance of Stock Options
20/09/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”) is [...]
New TRU NIAGEN PRO Launched for Expansive Distribution by Healthcare Practitioners
20/09/2018
Addressing aging population, TRU NIAGEN PRO now available for distribution by healthcare practitioners for patient health and wellness IRVINE, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an [...]
HEXO soutient le programme d’information sur le cannabis de la Société gastro-intestinale
20/09/2018
GATINEAU, Québec, 20 sept. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX: HEXO ) s’intéresse beaucoup à la responsabilité sociale d’entreprise (RSE) et à cet égard, elle examine attentivement l’ [...]
Children Treated With Remestemcel-L Continue to Have Strong Survival Outcomes at Six Months in Mesoblast’s Phase 3 Trial for Acute Graft Versus Host Disease
20/09/2018
Preparations for Biologics License Application (BLA) Filing Underway NEW YORK and MELBOURNE, Australia, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced continued strong [...]

Pages